DE60124117T8 - Aminothiazol-derivate enthaltende pharmazeutische zusammensetzungen zur behandlung von motorischen störungen des kolons - Google Patents

Aminothiazol-derivate enthaltende pharmazeutische zusammensetzungen zur behandlung von motorischen störungen des kolons Download PDF

Info

Publication number
DE60124117T8
DE60124117T8 DE60124117T DE60124117T DE60124117T8 DE 60124117 T8 DE60124117 T8 DE 60124117T8 DE 60124117 T DE60124117 T DE 60124117T DE 60124117 T DE60124117 T DE 60124117T DE 60124117 T8 DE60124117 T8 DE 60124117T8
Authority
DE
Germany
Prior art keywords
aminothiazol
colon
pharmaceutical compositions
derivatives containing
containing pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE60124117T
Other languages
English (en)
Other versions
DE60124117D1 (de
DE60124117T2 (de
Inventor
Shigeru Osato-gun UEKI
Yuko Osato-gun HORI
Yugo Osato-gun MATSUNAGA
Masaaki Osato-gun NAGASAWA
Hiroyasu Osato-gun NISHIOKA
Masakazu Osato-gun MURATA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd filed Critical Zeria Pharmaceutical Co Ltd
Publication of DE60124117D1 publication Critical patent/DE60124117D1/de
Application granted granted Critical
Publication of DE60124117T2 publication Critical patent/DE60124117T2/de
Publication of DE60124117T8 publication Critical patent/DE60124117T8/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60124117T 2000-09-08 2001-05-10 Aminothiazol-derivate enthaltende pharmazeutische zusammensetzungen zur behandlung von motorischen störungen des kolons Active DE60124117T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000273025 2000-09-08
JP2000273025 2000-09-08
PCT/JP2001/003893 WO2002020010A1 (en) 2000-09-08 2001-05-10 Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions

Publications (3)

Publication Number Publication Date
DE60124117D1 DE60124117D1 (de) 2006-12-07
DE60124117T2 DE60124117T2 (de) 2007-02-15
DE60124117T8 true DE60124117T8 (de) 2007-05-31

Family

ID=18759044

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124117T Active DE60124117T8 (de) 2000-09-08 2001-05-10 Aminothiazol-derivate enthaltende pharmazeutische zusammensetzungen zur behandlung von motorischen störungen des kolons

Country Status (14)

Country Link
US (1) US6673368B2 (de)
EP (1) EP1315488B1 (de)
JP (1) JP4876367B2 (de)
KR (1) KR100776298B1 (de)
CN (1) CN1264512C (de)
AT (1) ATE343384T1 (de)
AU (2) AU2001256685B2 (de)
CA (1) CA2419666C (de)
DE (1) DE60124117T8 (de)
DK (1) DK1315488T3 (de)
ES (1) ES2273838T3 (de)
PT (1) PT1315488E (de)
TW (1) TWI296522B (de)
WO (1) WO2002020010A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1493441T1 (sl) * 2002-04-08 2011-12-30 Zeria Pharm Co Ltd Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano
EA014685B1 (ru) 2003-04-25 2010-12-30 Джилид Сайэнс, Инк. Фосфонатсодержащие антивирусные соединения (варианты) и фармацевтическая композиция на их основе
UA88313C2 (ru) 2004-07-27 2009-10-12 Гилиад Сайенсиз, Инк. Фосфонатные аналоги соединений ингибиторов вич
EP1797084A1 (de) * 2004-09-20 2007-06-20 4Sc Ag Neue heterocyclische nf-kb-inhibitoren
KR100670974B1 (ko) * 2006-09-18 2007-02-28 (주) 리드제넥스 티아졸 유도체의 조합화학적 방법에 의한 분자다양성구축기술
EA018308B1 (ru) 2008-07-08 2013-07-30 Джилид Сайэнс, Инк. Соли соединений ингибиторов вич
JP5885738B2 (ja) * 2011-04-13 2016-03-15 オリンパス株式会社 単一発光粒子検出を用いた光分析装置、光分析方法及び光分析用コンピュータプログラム
CN104130207B (zh) * 2014-07-07 2016-08-24 湖北华世通生物医药科技有限公司 阿考替胺氢溴酸盐水合物及其晶型的制备方法
PL3661937T3 (pl) 2017-08-01 2021-12-20 Gilead Sciences, Inc. Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574054A (en) 1992-05-12 1996-11-12 Zeria Pharmaceutical Co., Ltd. Quaternary ammonium salts and use thereof as medicine
CN1063442C (zh) 1995-05-18 2001-03-21 泽里新药工业株式会社 氨基噻唑衍生物、含有它们的药物组合物及其用途
ATE231137T1 (de) * 1996-10-24 2003-02-15 Zeria Pharm Co Ltd Substituierte benzoylthiazolderivate und sie enthaltende medikamente
JPH10212271A (ja) * 1997-01-31 1998-08-11 Zeria Pharmaceut Co Ltd Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
ES2198719T3 (es) 1997-06-24 2004-02-01 Zeria Pharmaceutical Co., Ltd. Procedimiento de produccion de los derivados de 2-hidroxibenzamida.

Also Published As

Publication number Publication date
CA2419666C (en) 2009-10-27
EP1315488B1 (de) 2006-10-25
EP1315488A2 (de) 2003-06-04
DE60124117D1 (de) 2006-12-07
ES2273838T3 (es) 2007-05-16
AU5668501A (en) 2002-03-22
AU2001256685B2 (en) 2005-12-22
KR20030029881A (ko) 2003-04-16
WO2002020010A1 (en) 2002-03-14
TWI296522B (en) 2008-05-11
ATE343384T1 (de) 2006-11-15
PT1315488E (pt) 2007-01-31
CN1460020A (zh) 2003-12-03
JP4876367B2 (ja) 2012-02-15
DE60124117T2 (de) 2007-02-15
US6673368B2 (en) 2004-01-06
KR100776298B1 (ko) 2007-11-13
JP2004508328A (ja) 2004-03-18
CA2419666A1 (en) 2003-02-26
CN1264512C (zh) 2006-07-19
DK1315488T3 (da) 2007-02-12
US20020051805A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
MA26718A1 (fr) Derives de quinoleine-2-one a substituant heteroaryle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MY130668A (en) Isothiazole derivatives useful as anticancer agents
KR920008024A (ko) 퀴놀린 유도체
DE60124117T8 (de) Aminothiazol-derivate enthaltende pharmazeutische zusammensetzungen zur behandlung von motorischen störungen des kolons
CA2423007A1 (en) Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
MA28286A1 (fr) Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant
EP1277744A4 (de) Oxadiazolderivate mit antikrebswirkung
DE60024857D1 (de) Neue verbindungen
KR900004714A (ko) 신규의 3,4-디아미노 퀴놀린 및 피리딘계 화합물
AP9801377A0 (en) Tricyclic erythromycin derivatives.
DE69933885D1 (de) Triphenylbutenderivate zur behandlung von neurologischen störungen
ATE239711T1 (de) Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
KR960706476A (ko) 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action)
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
MA26721A1 (fr) Derives de 2-aminopyridine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE243202T1 (de) Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten
CA2374643A1 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
HUP9700392A1 (hu) Egy vagy két hatóanyagot tartalmazó kardioprotektív hatású gyógyszerkészítmények
RU2347783C2 (ru) Производные диазепана, их применение в качестве ингибиторов lfa, способ лечения заболеваний, опосредованных взаимодействием с lfa-1/icam-1
KR950703341A (ko) 항부정맥제
GB2333293B (en) Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide used as anti cancer compounds
DE60026161D1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: UEKI, SHIGERU, OSATO-GUN, SAITAMA 360-0111, JP

Inventor name: HORI, YUKO, OSATO-GUN, SAITAMA 360-0111, JP

Inventor name: MATSUNAGA, YUGO, OSATO-GUN, SAITAMA 360-0111, JP

Inventor name: NAGASAWA, MASAAKI, OSATO-GUN, SAITAMA 360-0111, JP

Inventor name: NISHIOKA, HIROYASU, OSATO-GUN, SAITAMA 360-011, JP

Inventor name: MURATA, MASAKAZU, OSATO-GUN, SAITAMA 360-0111, JP

8364 No opposition during term of opposition